Center for Biologics Evaluation and Research - PDFSEARCH.IO - Document Search Engine

Center for Biologics Evaluation and Research
Results: 1843

#	Item
21	U.S. Department of Health & Human Services U.S. Food and Drug Administration FDA Facts: FDA’s Medical Countermeasures Initiative (MCMi) Add to Reading List Source URL: www.fda.gov Language: English Clinical research Center for Biologics Evaluation and Research Public Readiness and Emergency Preparedness Act Center for Devices and Radiological Health Influenza vaccine Influenza Medicine Health Food and Drug Administration
22	WOLLO UNIVERSITY DESSIE CAMPUS OFFICE OF THE REGISTRAR COLLEGE OF BUSINESS AND ECONOMICS COOPERATIVE 2d SEMISTER 2006 E.C 2005 Entry REGULAR LIST NO 1 Add to Reading List Source URL: www.wu.edu.et Language: English - Date: 2014-10-07 03:18:53 WOUR Medicine Biology Health Food and Drug Administration Center for Biologics Evaluation and Research Influenza
23	Missing Data Issues in Regulatory Clinical Trials Lisa M. LaVange, PhD Office of Biostatistics OTS/CDER/US FDA Add to Reading List Source URL: www.jpma.or.jp Language: English - Date: 2015-02-24 20:15:37 Clinical research Center for Drug Evaluation and Research Bioequivalence Center for Biologics Evaluation and Research Abbreviated New Drug Application Drug development Biologic Biostatistics Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Pharmaceutical sciences Pharmacology
24	WOLLO UNIVERSITY DESSIE CAMPUS OFFICE OF THE REGISTRAR COLLEGE OF BUSINESS AND ECONOMICS MARKETING 2d SEMISTER 2006 E.C 2005 Entry REGULAR LIST NO 1 2 Add to Reading List Source URL: www.wu.edu.et Language: English - Date: 2014-10-07 03:21:19 Medicine Biology Health Food and Drug Administration WOUR Center for Biologics Evaluation and Research
25	Draft Guidance for Entities Considering Whether to Register Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Federal Food Drug and Cosmetic Act Compounding Center for Biologics Evaluation and Research Title 21 of the Code of Federal Regulations Good manufacturing practice Center for Drug Evaluation and Research Office of Regulatory Affairs Abbreviated New Drug Application Food and Drug Administration Medicine Health
26	This document is scheduled to be published in the Federal Register on[removed]and available online at http://federalregister.gov/a[removed], and on FDsys.gov[removed]P DEPARTMENT OF HEALTH AND HUMAN SERVICES Add to Reading List Source URL: s3.amazonaws.com Language: English - Date: 2015-04-03 08:46:17 Health Center for Biologics Evaluation and Research FDA Warning Letter Structured Product Labeling Food and Drug Administration Medicine Clinical research
27	Federal Register / Vol. 80, No[removed]Tuesday, March 31, [removed]Notices The Food and Drug Administration (FDA) is announcing a request for additional comments on the chemistry, manufacturing, and control (CMC) information Add to Reading List Source URL: www.gpo.gov Language: English - Date: 2015-03-31 08:02:18 Health Investigational New Drug Drug development Regulatory requirement Center for Biologics Evaluation and Research Prescription Drug User Fee Act New Drug Application ClinicalTrials.gov Structured Product Labeling Food and Drug Administration Medicine Pharmaceutical sciences
28	Vaccine Safety Scientific Agenda Add to Reading List Source URL: www.hhs.gov Language: English - Date: 2015-04-14 00:30:46 Health Drug safety Food and Drug Administration Centers for Disease Control and Prevention Public safety Vaccine Adverse Event Reporting System Influenza vaccine Advisory Committee on Immunization Practices Center for Biologics Evaluation and Research Medicine Vaccination Vaccines
29	Federal Register / Vol. 80, No[removed]Tuesday, March 31, [removed]Notices Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Hypertension, Thrombosis, Vascular Inflammation and Dysfunct Add to Reading List Source URL: www.gpo.gov Language: English - Date: 2015-03-31 08:02:18 Research New Drug Application Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Investigational New Drug Clinical research ClinicalTrials.gov Structured Product Labeling Food and Drug Administration Health Medicine
30	Federal Register / Vol. 80, No[removed]Friday, April 3, [removed]Notices trading in a range from 0 to 1⁄4 percent. The Committee directs the Desk to undertake open market operations as necessary to maintain such conditions Add to Reading List Source URL: www.gpo.gov Language: English - Date: 2015-04-03 10:00:56 Pharmaceutical sciences Federal Food Drug and Cosmetic Act Center for Biologics Evaluation and Research Dermatologic and Ophthalmic Drugs Advisory Committee Medical device Medicine Food and Drug Administration Health